Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:e300-e301
doi: 10.1161/01.CIR.0000131490.97194.21
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vida, V.
Right arrow Articles by Basso, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vida, V.
Right arrow Articles by Basso, C.
Related Collections
Right arrow Structure
Right arrow Echocardiography
Right arrow CV surgery: other

(Circulation. 2004;109:e300-e301.)
© 2004 American Heart Association, Inc.


Images in Cardiovascular Medicine

Left Ventricular Mass After Treatment With Chemotherapic Drugs

Vladimiro Vida, MD; Roberta Biffanti, MD; Gaetano Thiene, MD; Giovanni Stellin, MD; Ornella Milanesi, MD; Cristina Basso, MD, PhD

From the Institute of Paediatric Cardiac Surgery (V.V., G.S.), Paediatrics (R.B., C.B.) and Pathological Anatomy (G.T., O.M.), University of Padua Medical School, Padua, Italy.

Correspondence to Cristina Basso, MD, PhD, Institute of Pathological Anatomy, University of Padua Medical School, Via A. Gabelli, 61–35121 Padova, Italy. E-mail cristina.basso@unipd.it


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

A 23-year-old man with acute myeloid leukemia had been treated with chemotherapic agents and an autologous stem cell transplant at the age of 11 and had received a transplant of matched unrelated donor stem cells at the age of 22 for myelodysplastic syndrome. During a recent hospitalization for lung impairment, chest x-ray, computed tomography scan, and sputum cultures were suggestive of fungal infection with Aspergillus pneumoniae, and the patient was treated with Amphotericin B (GILEAD Sciences) and Caspofungin (Merck-Sharpe&Dohme Ltd) for 1 month. Three months after discharge, he underwent cardiac evaluation because of systemic hypertension. Two-dimensional echocardiography showed an oval (1.2x1.4 cm) floating mass in the left ventricular outflow tract near the aortic valve (Figure 1A and 1B). With the aid of cardiopulmonary bypass, cardioplegic arrest, and transverse aortic incision, the mass was excised from its base on the ventricular septum, 3 centimeters below the commissure between the right and left aortic cusps. The mass (Figure 2A) was whitish, friable, and oval shaped with a rough surface. Histologically, it consisted of characteristic branching septate hyphae enmeshed within fibrinous material (Figure 2B). With a diagnosis of left ventricular aspergilloma, the patient was treated with Voriconazole (Pfizer) for 7 weeks. No echocardiographic evidence of recurrence was present at the 4 months’ follow-up.


Figure Removed (Available Only in the Full Text)
View larger version (89K):
[in this window]
[in a new window]
 
Figure 1. Two-dimensional echocardiography. Long axis view shows a solid floating mass 1.2x1.4 cm in size attached to the ventricular septum. A, diastole; B, systole. A indicates aspergilloma; AO, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
ESC Textbook of Cardiovascular MedicineHome page
G. Thiene, M. Valente, M. Lombardi, and C. Basso
CHAPTER 20 Tumours of the Heart
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]